
Gilead Sciences will move its US manufacturing plant about 15 minutes down the road to a 23-acre site in the …
Gilead Sciences has been sent a warning letter from the FDA after failing to rectify problems at a facility used to …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

